Chief Imam of All India Imam Organization, Dr. Imam Umer Ahmed Ilyas, evinces keen interest in the eradication of Thalassemia & Sickle Cell Disease
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
India has a pivotal role in eliminating TB
He is Proficient in overseeing and leading teams for running successful business operations
Proposed combination enhances Pfizer’s position as a leading company in oncology
Kyndryl's multi-cloud management solution leverages AI-based, cloud-hosted models to provide real-time metrics, events, logs, and traces
Natural Capsules Limited's shareholding will be reduced to 89.99%
Subscribe To Our Newsletter & Stay Updated
